These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 14612150)

  • 21. Na+ and the substrate permeation pathway in dopamine transporters.
    Chen N; Reith ME
    Eur J Pharmacol; 2003 Oct; 479(1-3):213-21. PubMed ID: 14612151
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cocaine induction of dopamine transporter trafficking to the plasma membrane.
    Little KY; Elmer LW; Zhong H; Scheys JO; Zhang L
    Mol Pharmacol; 2002 Feb; 61(2):436-45. PubMed ID: 11809869
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rapid regulation of dopamine transporter function by substrates, blockers and presynaptic receptor ligands.
    Gulley JM; Zahniser NR
    Eur J Pharmacol; 2003 Oct; 479(1-3):139-52. PubMed ID: 14612145
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dopamine efflux via wild-type and mutant dopamine transporters: alanine substitution for proline-572 enhances efflux and reduces dependence on extracellular dopamine, sodium and chloride concentrations.
    Itokawa M; Lin Z; Uhl GR
    Brain Res Mol Brain Res; 2002 Dec; 108(1-2):71-80. PubMed ID: 12480180
    [TBL] [Abstract][Full Text] [Related]  

  • 25. What can be learned from studies of multisubstrate mechanisms of neuronal dopamine transport?
    Schenk JO; George SE; Schumacher PD
    Eur J Pharmacol; 2003 Oct; 479(1-3):223-8. PubMed ID: 14612152
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dopamine transporter-mediated cytotoxicity of beta-carbolinium derivatives related to Parkinson's disease: relationship to transporter-dependent uptake.
    Storch A; Hwang YI; Gearhart DA; Beach JW; Neafsey EJ; Collins MA; Schwarz J
    J Neurochem; 2004 May; 89(3):685-94. PubMed ID: 15086525
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Monoamine transporter inhibitors and norepinephrine reduce dopamine-dependent iron toxicity in cells derived from the substantia nigra.
    Paris I; Martinez-Alvarado P; Perez-Pastene C; Vieira MN; Olea-Azar C; Raisman-Vozari R; Cardenas S; Graumann R; Caviedes P; Segura-Aguilar J
    J Neurochem; 2005 Mar; 92(5):1021-32. PubMed ID: 15715653
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of a novel partial inhibitor of dopamine transporter among 4-substituted 2-phenylquinazolines.
    Ananthan S; Saini SK; Khare R; Clayton SD; Dersch CM; Rothman RB
    Bioorg Med Chem Lett; 2002 Aug; 12(16):2225-8. PubMed ID: 12127543
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of several cations on the neuronal uptake of dopamine and the specific binding of [3H]GBR 12783: attempts to characterize the Na+ dependence of the neuronal transport of dopamine.
    Amejdki-Chab N; Benmansour S; Costentin J; Bonnet JJ
    J Neurochem; 1992 Nov; 59(5):1795-804. PubMed ID: 1402923
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Binding domains for blockers and substrates on the cloned human dopamine transporter studied by protection against N-ethylmaleimide-induced reduction of 2 beta-carbomethoxy-3 beta-(4-fluorophenyl)[3H]tropane ([3H]WIN 35,428) binding.
    Reith ME; Xu C; Coffey LL
    Biochem Pharmacol; 1996 Nov; 52(9):1435-46. PubMed ID: 8937455
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of N-glycosylation in function and surface trafficking of the human dopamine transporter.
    Li LB; Chen N; Ramamoorthy S; Chi L; Cui XN; Wang LC; Reith ME
    J Biol Chem; 2004 May; 279(20):21012-20. PubMed ID: 15024013
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Delineation of an endogenous zinc-binding site in the human dopamine transporter.
    Norregaard L; Frederiksen D; Nielsen EO; Gether U
    EMBO J; 1998 Aug; 17(15):4266-73. PubMed ID: 9687495
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Drug discrimination in methamphetamine-trained monkeys: effects of monoamine transporter inhibitors.
    Czoty PW; Ramanathan CR; Mutschler NH; Makriyannis A; Bergman J
    J Pharmacol Exp Ther; 2004 Nov; 311(2):720-7. PubMed ID: 15240827
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis and dopamine transporter binding affinities of 3alpha-benzyl-8-(diarylmethoxyethyl)-8-azabicyclo[3.2.1]octanes.
    Bradley AL; Izenwasser S; Wade D; Klein-Stevens C; Zhu N; Trudell ML
    Bioorg Med Chem Lett; 2002 Sep; 12(17):2387-90. PubMed ID: 12161139
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dopamine transporters are involved in the onset of hypoxia-induced dopamine efflux in striatum as revealed by in vivo microdialysis.
    Orset C; Parrot S; Sauvinet V; Cottet-Emard JM; Bérod A; Pequignot JM; Denoroy L
    Neurochem Int; 2005 Jun; 46(8):623-33. PubMed ID: 15863240
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interaction of cocaine and dopamine transporter inhibitors on behavior and neurochemistry in monkeys.
    Ginsburg BC; Kimmel HL; Carroll FI; Goodman MM; Howell LL
    Pharmacol Biochem Behav; 2005 Mar; 80(3):481-91. PubMed ID: 15740791
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification and characterization of a novel allosteric modulator (SoRI-6238) of the serotonin transporter.
    Nandi A; Dersch CM; Kulshrestha M; Ananthan S; Rothman RB
    Synapse; 2004 Sep; 53(3):176-83. PubMed ID: 15236350
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relationship between blockade of dopamine transporters by oral methylphenidate and the increases in extracellular dopamine: therapeutic implications.
    Volkow ND; Wang GJ; Fowler JS; Logan J; Franceschi D; Maynard L; Ding YS; Gatley SJ; Gifford A; Zhu W; Swanson JM
    Synapse; 2002 Mar; 43(3):181-7. PubMed ID: 11793423
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Structure-activity relationship studies of highly selective inhibitors of the dopamine transporter: N-benzylpiperidine analogues of 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazine.
    Greiner E; Prisinzano T; Johnson EM; Dersch CM; Marcus J; Partilla JS; Rothman RB; Jacobson AE; Rice KC
    J Med Chem; 2003 Apr; 46(8):1465-9. PubMed ID: 12672246
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A triple mutation in the second transmembrane domain of mouse dopamine transporter markedly decreases sensitivity to cocaine and methylphenidate.
    Chen R; Han DD; Gu HH
    J Neurochem; 2005 Jul; 94(2):352-9. PubMed ID: 15998286
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.